Stock 300147 XIANGXUE PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
3.98 CNY -1.97% Intraday chart for Xiangxue Pharmaceutical Co.,Ltd. -19.11% -22.72%
04-29 Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,030 5,783 5,842 5,266 3,961 3,406
Enterprise Value (EV) 1 6,501 7,941 9,142 8,347 6,252 5,689
P/E ratio 68.2 x 73.8 x 59.7 x -7.76 x -7.49 x -8.73 x
Yield 0.55% 0.52% - - - -
Capitalization / Revenue 1.61 x 2.08 x 1.9 x 1.77 x 1.81 x 1.48 x
EV / Revenue 2.6 x 2.85 x 2.98 x 2.81 x 2.86 x 2.47 x
EV / EBITDA 17.7 x 26.1 x 20.5 x 68.4 x 168 x 20 x
EV / FCF -48.8 x 27.9 x -8.58 x 154 x 9.81 x 302 x
FCF Yield -2.05% 3.59% -11.6% 0.65% 10.2% 0.33%
Price to Book 1.17 x 1.66 x 1.5 x 2.63 x 1.62 x 1.73 x
Nbr of stocks (in thousands) 656,337 652,709 652,709 652,594 652,511 661,279
Reference price 2 6.140 8.860 8.950 8.070 6.070 5.150
Announcement Date 29/04/19 19/05/20 28/04/21 22/04/22 21/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,504 2,786 3,072 2,971 2,187 2,299
EBITDA 1 368.2 304.4 445 122.1 37.13 284.1
EBIT 1 256.1 190.2 311.8 -22.39 -197.4 53.79
Operating Margin 10.23% 6.82% 10.15% -0.75% -9.03% 2.34%
Earnings before Tax (EBT) 1 112 121.1 166.1 -635.8 -514.7 -389
Net income 1 56.44 79.97 98.42 -688.5 -533.2 -389
Net margin 2.25% 2.87% 3.2% -23.18% -24.38% -16.92%
EPS 2 0.0900 0.1200 0.1500 -1.040 -0.8100 -0.5900
Free Cash Flow 1 -133.3 285.1 -1,065 54.29 637.4 18.87
FCF margin -5.32% 10.23% -34.67% 1.83% 29.14% 0.82%
FCF Conversion (EBITDA) - 93.65% - 44.47% 1,716.71% 6.64%
FCF Conversion (Net income) - 356.44% - - - -
Dividend per Share 2 0.0340 0.0460 - - - -
Announcement Date 29/04/19 19/05/20 28/04/21 22/04/22 21/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -54.38
Net margin -
EPS 2 -0.0820
Dividend per Share -
Announcement Date 28/04/22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2,471 2,158 3,300 3,081 2,291 2,284
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.711 x 7.09 x 7.414 x 25.24 x 61.71 x 8.039 x
Free Cash Flow 1 -133 285 -1,065 54.3 637 18.9
ROE (net income / shareholders' equity) 2.23% 3.19% 3.39% -16.5% -15.4% -16%
ROA (Net income/ Total Assets) 1.79% 1.42% 2.14% -0.12% -1.19% 0.4%
Assets 1 3,150 5,614 4,605 580,008 44,796 -97,902
Book Value Per Share 2 5.260 5.350 5.950 3.070 3.750 2.980
Cash Flow per Share 2 1.000 0.7600 1.000 0.2000 0.2600 0.2300
Capex 1 495 661 707 563 367 56
Capex / Sales 19.78% 23.73% 23.03% 18.94% 16.79% 2.44%
Announcement Date 29/04/19 19/05/20 28/04/21 22/04/22 21/04/23 29/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
XIANGXUE PHARMACEUTICAL CO.,LTD. Stock Xiangxue Pharmaceutical Co.,Ltd.
-22.72% 372M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+42.38% 6.28B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.86% 4.51B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+6.36% 3.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-11.28% 3.13B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.23% 2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+45.24% 1.96B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-0.98% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-11.32% 1.56B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 300147 Stock
  4. Financials Xiangxue Pharmaceutical Co.,Ltd.